Lipomas in Dogs: When Fatty Lumps Need Attention

By Emiel Maddens  ·  Reviewed in consultation with licensed veterinary professionals  ·  Updated June 2026  ·  10 min read

Photo by Mikhail Nilov on Pexels

Finding a lump on your dog is always a moment of concern, but in many cases, the culprit is a lipoma, one of the most common and benign tumors encountered in veterinary practice. Lipomas are composed of mature adipocytes (fat cells) that proliferate to form a well-defined, encapsulated mass within the subcutaneous tissue. These soft, doughy, freely movable lumps can appear anywhere on the body but are most commonly found on the trunk, chest, abdomen, and proximal limbs. While the discovery of any new mass warrants veterinary evaluation, lipomas rarely pose a threat to the dog's health and can often be monitored rather than surgically removed.

The prevalence of lipomas increases with age, with most cases diagnosed in dogs over 8 years old. Certain breeds demonstrate a genetic predisposition to lipoma development, with Labrador Retrievers, Golden Retrievers, Weimaraners, Doberman Pinschers, and Miniature Schnauzers among the most commonly affected. Overweight dogs are more frequently diagnosed with lipomas than lean dogs, though it is debated whether obesity truly predisposes to lipoma formation or whether the excess subcutaneous fat simply makes lipomas more noticeable during physical examination. Female dogs may be slightly more commonly affected than males, though lipomas occur regularly in both sexes.

While the vast majority of lipomas are harmless and require only periodic monitoring, it is important to understand that not all fatty lumps are created equal. Infiltrative lipomas, a less common variant, grow by extending between muscle fibers and fascial planes rather than remaining encapsulated, making them much harder to remove surgically and more likely to recur. Liposarcomas, the malignant counterpart to lipomas, are rare but require fundamentally different treatment approaches. Accurate diagnosis through fine needle aspirate cytology or biopsy ensures that each mass receives appropriate management, whether that is watchful monitoring, elective surgical removal, or aggressive intervention.

Understanding Lipomas: Biology and Behavior

What Lipomas Are Made Of

A lipoma consists of a well-organized collection of mature, normal-appearing fat cells enclosed within a thin fibrous capsule. Unlike malignant tumors, the fat cells in a lipoma are indistinguishable from normal adipocytes under the microscope, suggesting that lipoma formation results from localized hyperplasia (increased cell numbers) rather than neoplastic transformation. The fibrous capsule that surrounds the mass creates a clear boundary between the lipoma and the surrounding normal tissue, which is why lipomas feel distinctly movable when palpated and why they can typically be cleanly separated from adjacent structures during surgical removal.

Growth Patterns

Lipomas generally grow slowly over months to years, and many reach a stable size and remain unchanged indefinitely. The growth rate varies among individual lipomas, with some remaining small and barely palpable while others gradually enlarge to considerable dimensions. It is not uncommon for lipomas to reach 10 to 15 centimeters or more in diameter, particularly in large breed dogs where the mass has ample subcutaneous space to expand. Very large lipomas may become pendulous, hanging from the body wall and swinging with movement, which can cause skin irritation, mechanical discomfort, and cosmetic concern for the owner.

Multiple Lipomas

Many dogs that develop one lipoma will subsequently develop additional lipomas at other body locations over time. This tendency toward multiple lipomas is particularly pronounced in certain breeds, with some older Labrador Retrievers and Weimaraners developing ten or more lipomas scattered across their bodies. Each new lipoma should receive individual diagnostic evaluation, as the development of a new mass in a dog with known lipomas does not guarantee that the new mass is also a lipoma. Mast cell tumors, in particular, can closely mimic the soft, subcutaneous presentation of lipomas on physical examination alone.

Breed Predisposition and Risk Factors

High-Risk Breeds

Several breeds demonstrate a clear genetic predisposition to lipoma development. Labrador Retrievers are perhaps the most commonly affected breed, with lipomas representing a frequent clinical finding in dogs over 7 years of age. Weimaraners have a particularly strong predisposition and may develop lipomas at younger ages than other breeds. Doberman Pinschers, Miniature Schnauzers, Cocker Spaniels, and mixed-breed dogs of medium to large size are also commonly affected. The genetic factors underlying breed predisposition are not fully characterized but likely involve variations in genes regulating adipocyte proliferation and growth control.

Age and Body Condition

The risk of lipoma development increases steadily with age, with most cases diagnosed in dogs between 8 and 14 years old. Lipomas are uncommon in dogs younger than 5 years, and their development in a young dog should prompt careful diagnostic evaluation to ensure an accurate diagnosis. Overweight and obese dogs are diagnosed with lipomas more frequently than lean dogs, though the relationship between obesity and lipoma formation is complex. Some researchers suggest that the metabolic and hormonal changes associated with obesity may promote adipocyte proliferation, while others argue that lipomas in lean tissue simply escape detection more readily.

Regardless of breed or body condition, any new lump or bump on a dog should receive veterinary evaluation to establish a definitive diagnosis. The clinical similarity between lipomas and other, potentially more serious masses makes professional assessment essential for appropriate management decisions.

Regular veterinary check-ups ensure each new lump is properly diagnosed.

Photo by Karsten Winegeart on Unsplash

Diagnosis: Fine Needle Aspirate and Beyond

Fine Needle Aspirate Cytology

Fine needle aspirate (FNA) is the standard first-line diagnostic tool for evaluating subcutaneous masses suspected to be lipomas. The procedure involves inserting a small-gauge needle (22 to 25 gauge) into the mass, applying suction with an attached syringe, and collecting a small sample of cells. The aspirated material is spread onto a glass slide, stained, and examined under the microscope. Lipomas yield a characteristic sample of mature, well-differentiated adipocytes that appear as large, clear cells with eccentric nuclei, identical in appearance to normal fat cells. The procedure is quick, minimally painful, and can typically be performed without sedation.

Interpreting FNA Results

While FNA is highly reliable for confirming the fatty composition of a mass, it has some inherent limitations. The primary challenge is that the aspirated cells from a lipoma are morphologically identical to normal subcutaneous fat, making it theoretically possible to miss the mass and sample adjacent normal tissue instead. For this reason, experienced clinicians evaluate the overall cellularity of the sample, the presence of capillary blood vessels, and the clinical correlation with the mass location. FNA cannot reliably distinguish a benign lipoma from an infiltrative lipoma or a well-differentiated liposarcoma, as the individual cells may appear identical in all three conditions. When clinical suspicion is high for an atypical lipoma variant, excisional biopsy with histopathological examination provides definitive diagnosis.

Advanced Imaging

For masses in locations where surgical planning is complex, or when infiltrative lipoma is suspected, advanced imaging modalities provide valuable information about mass extent and tissue involvement. Ultrasound can characterize the internal structure of the mass, define its boundaries, and identify tissue planes between the lipoma and adjacent structures. CT (computed tomography) and MRI (magnetic resonance imaging) are particularly valuable for infiltrative lipomas, providing detailed three-dimensional visualization of the mass's extension between muscle groups and along fascial planes. This information is essential for surgical planning when removal is indicated, as it allows the surgeon to anticipate the extent of dissection needed.

Infiltrative Lipomas: A Different Challenge

How They Differ from Simple Lipomas

Infiltrative lipomas, while composed of the same mature fat cells as simple lipomas, differ fundamentally in their growth pattern. Instead of forming a discrete, encapsulated mass, infiltrative lipomas extend fingers of fat tissue between individual muscle fibers, along fascial planes, and through connective tissue boundaries. This infiltrative growth pattern makes these masses poorly defined on palpation, firmly attached to underlying structures, and considerably more difficult to surgically remove with clean margins. Infiltrative lipomas do not metastasize to distant sites, but their local invasive behavior can cause progressive functional impairment if they involve muscles, tendons, or nerves.

Clinical Impact and Location

Infiltrative lipomas most commonly affect the limbs and trunk, and their clinical impact depends heavily on their anatomical location. A small infiltrative lipoma in the subcutaneous tissue of the trunk may cause minimal problems, while a similarly sized mass infiltrating the muscles of the forelimb can produce progressive lameness, muscle atrophy, and significant functional impairment. The insidious growth pattern means that by the time clinical signs become apparent, the mass may be substantially larger and more deeply infiltrated than expected from the external examination alone.

Treatment Considerations

Surgical excision is the treatment of choice for infiltrative lipomas, but the diffuse, infiltrative growth pattern makes complete removal challenging. Wide surgical margins, including the removal of apparently normal tissue surrounding the mass, are necessary to reduce the risk of recurrence. Despite aggressive surgery, recurrence rates for infiltrative lipomas are reported at 36% to 50% in veterinary literature. Radiation therapy, administered either before or after surgery, has been shown to improve local control rates and reduce recurrence in some studies. Limb amputation may be considered for infiltrative lipomas that extensively involve the musculature of an extremity and cannot be adequately controlled with conservative surgery and radiation.

Liposarcoma: The Malignant Counterpart

Recognizing the Risk

Liposarcomas are malignant tumors of fat tissue that, while rare in dogs, represent the important malignant differential diagnosis for any fatty mass. These tumors consist of atypical, poorly differentiated fat cells that grow more rapidly and aggressively than benign lipomas. Liposarcomas may be firm or hard rather than soft and doughy, they may be fixed to underlying structures rather than freely movable, and they may grow more rapidly than typical lipomas. However, some well-differentiated liposarcomas can closely mimic the clinical appearance of a benign lipoma, making diagnostic evaluation essential for every new mass.

Diagnosis and Prognosis

Definitive diagnosis of liposarcoma requires histopathological examination of a biopsy or excision specimen, as FNA cytology may not reliably distinguish well-differentiated liposarcoma from benign lipoma. The pathologist evaluates the degree of cellular atypia, mitotic activity, and tissue architecture to grade the tumor and predict its biological behavior. Well-differentiated liposarcomas have a relatively favorable prognosis with low metastatic rates, while poorly differentiated or high-grade liposarcomas carry a more guarded prognosis due to the potential for local recurrence and distant metastasis. Wide surgical excision with clean histological margins is the cornerstone of treatment.

The rarity of liposarcoma should not create complacency about fatty masses. Every new lump deserves diagnostic evaluation, and masses that grow rapidly, feel firm, or appear fixed to underlying tissues should receive prompt veterinary attention. Early detection and complete surgical excision offer the best chance of cure for the rare liposarcoma encountered among the many benign lipomas that veterinary patients develop.

Monitoring Versus Surgical Removal

When Monitoring Is Appropriate

The majority of simple lipomas can be safely monitored rather than surgically removed. Monitoring is appropriate when the lipoma has been confirmed by FNA cytology, is growing slowly or not at all, is not impeding movement or causing discomfort, and is in a location where it does not interfere with the dog's daily activities. An effective monitoring strategy involves measuring the mass at regular intervals (monthly measurements recorded in a journal or photograph documentation) and scheduling veterinary rechecks every 6 to 12 months or sooner if changes are noted. Any rapid increase in size, change in texture, or development of associated pain should prompt reevaluation.

Indications for Surgical Removal

Surgical removal of a lipoma is recommended in several specific circumstances. Large lipomas that impede movement, particularly those located in the axillary region, medial thigh, or ventral chest where they interfere with limb mobility, benefit from elective removal. Rapidly growing lipomas should be removed and submitted for histopathological examination to rule out infiltrative lipoma or liposarcoma. Lipomas that are causing visible discomfort, skin ulceration from friction, or significant cosmetic concern for the owner may also be removed electively. Additionally, lipomas in locations that will become more difficult to remove as they grow, such as the axilla or inguinal region, are often best addressed while they are still relatively small.

Surgical Considerations

Lipoma removal is generally a straightforward surgical procedure for simple, encapsulated masses. The surgeon makes an incision over the mass and uses blunt dissection to separate the lipoma from the surrounding tissue, taking advantage of the natural plane created by the fibrous capsule. Complete excision is typically achieved, and recurrence of simple lipomas at the same site is uncommon. Post-operative care involves standard wound management, exercise restriction during healing, and suture removal in 10 to 14 days. Surgical complications are rare but can include seroma formation (fluid accumulation at the surgical site), incisional dehiscence, and infection.

Living with a Dog with Lipomas

Maintaining Quality of Life

Dogs with lipomas, even multiple lipomas, typically enjoy an excellent quality of life. The masses themselves are painless and do not affect the dog's internal health, energy level, or longevity. Owners should focus on maintaining their dog's overall health through appropriate nutrition, regular exercise, and routine veterinary care rather than fixating on the presence of lipomas. Keeping the dog at a healthy body weight may slow the growth of existing lipomas and reduce the development of new ones, though this relationship is not definitively established.

Regular Veterinary Monitoring

Establishing a consistent monitoring schedule with your veterinarian ensures that any changes in existing lipomas or the development of new masses are detected promptly. At each veterinary visit, all known masses should be palpated, measured, and documented. Creating a body map that records the location and size of each mass provides a valuable reference for detecting changes over time. New masses should always receive FNA evaluation regardless of the number of confirmed lipomas already present, as the assumption that every new lump must be another lipoma can lead to delayed diagnosis of more serious conditions.

The most important takeaway for owners of dogs with lipomas is that these masses, while often cosmetically concerning, are overwhelmingly benign and rarely impact the dog's health or happiness. By working with your veterinarian to establish an appropriate monitoring and management plan, you can ensure your dog receives the right level of attention for each individual mass while avoiding unnecessary anxiety about a common and usually harmless condition.

Lipomas in Dogs FAQ

Q: Are lipomas cancerous?

No, lipomas are benign (non-cancerous) tumors composed of normal fat cells. They do not metastasize (spread) to other parts of the body and do not transform into malignant tumors over time. However, liposarcomas, the malignant counterpart, are a rare possibility that underscores the importance of diagnostic evaluation for every new mass. Fine needle aspirate cytology is the standard method for confirming a mass is a benign lipoma.

Q: Can lipomas shrink on their own?

Lipomas very rarely shrink spontaneously. In some cases, weight loss may modestly reduce the size of lipomas, but this effect is inconsistent and typically minor. Once established, lipomas tend to either remain stable in size or grow slowly over time. There are no proven non-surgical treatments, supplements, or dietary modifications that reliably shrink established lipomas.

Q: How many lipomas can a dog have?

There is no upper limit to the number of lipomas a dog can develop. Some dogs, particularly Labrador Retrievers, Weimaraners, and other predisposed breeds, may develop ten, twenty, or more lipomas scattered across their bodies over their lifetime. Each individual lipoma should receive its own diagnostic evaluation, as the presence of many confirmed lipomas does not guarantee that every new mass is also a lipoma.

Q: Should I be worried about my dog's lipoma growing?

Slow growth of a confirmed lipoma is common and generally not cause for alarm. However, rapid growth, defined as a noticeable increase in size over weeks rather than months, should prompt veterinary reevaluation, as it may indicate a different type of mass or a more aggressive lipoma variant. Any change in the texture, firmness, or mobility of an existing lipoma should also be reported to your veterinarian.

Q: Does diet affect lipoma development in dogs?

The relationship between diet and lipoma development is not well established in veterinary research. While some holistic practitioners suggest dietary modifications, there is no scientific evidence that specific diets prevent lipoma formation or shrink existing lipomas. Maintaining a healthy body weight through appropriate nutrition is generally recommended, as obesity may contribute to lipoma development, but there is no proven lipoma-specific dietary intervention.

Sources

Liptak, J.M., Forrest, L.J. (2013). Soft tissue sarcomas. In Withrow & MacEwen's Small Animal Clinical Oncology, 5th ed. Elsevier Saunders, 356-380.

Bergman, P.J., et al. (1994). Infiltrative lipoma in dogs: 56 cases (1986-1991). JAVMA, 205(2), 322-324.

McEntee, M.C., Thrall, D.E. (2001). Computed tomographic imaging of infiltrative lipoma in 22 dogs. Veterinary Radiology & Ultrasound, 42(3), 221-225.

Goldschmidt, M.H., Hendrick, M.J. (2002). Tumors of the skin and soft tissues. In Meuten, D.J. (Ed.), Tumors in Domestic Animals, 4th ed. Iowa State Press.

Dennis, M.M., et al. (2011). Prognostic factors for cutaneous and subcutaneous soft tissue sarcomas in dogs. Veterinary Pathology, 48(1), 73-84.

Rassnick, K.M. (2003). Lipomas and liposarcomas in dogs. Compendium on Continuing Education for the Practising Veterinarian, 25(11), 838-847.

Related Reading

• Mast Cell Tumors in Dogs, The most common malignant skin tumor and how to differentiate it
• Sebaceous Cysts in Dogs, Another common benign lump type and when treatment is needed
• Histiocytoma in Dogs, Benign button-like tumors that often resolve on their own
• Skin Tags and Warts in Dogs, When bumps and growths warrant veterinary evaluation

Emiel Maddens

Founder of Vetified. Develops topical antifungal and antimicrobial formulations for companion animals. Vetified products are listed on DailyMed and manufactured through FDA-registered facilities in the United States.